Mini,Acoustic-Electr,II,/members/van-voorden-gieterijen-bv/,Bass,www.fonteallalepre.com,Body,,Mahogany,,$160,MH-E,,Musical Instruments , Bass Guitars , Acoustic Acoustic-Electric Bas,Cordoba,Small Cordoba Mini II Industry No. 1 Bass MH-E Acoustic-Electr Mahogany Body Small Cordoba Mini II Industry No. 1 Bass MH-E Acoustic-Electr Mahogany Body Small $160 Cordoba Mini II Bass MH-E, Mahogany, Small Body, Acoustic-Electr Musical Instruments Bass Guitars Acoustic Acoustic-Electric Bas $160 Cordoba Mini II Bass MH-E, Mahogany, Small Body, Acoustic-Electr Musical Instruments Bass Guitars Acoustic Acoustic-Electric Bas Mini,Acoustic-Electr,II,/members/van-voorden-gieterijen-bv/,Bass,www.fonteallalepre.com,Body,,Mahogany,,$160,MH-E,,Musical Instruments , Bass Guitars , Acoustic Acoustic-Electric Bas,Cordoba,Small

Cordoba Mini II Industry No. 1 Spring new work Bass MH-E Acoustic-Electr Mahogany Body Small

Cordoba Mini II Bass MH-E, Mahogany, Small Body, Acoustic-Electr

$160

Cordoba Mini II Bass MH-E, Mahogany, Small Body, Acoustic-Electr

|||

Product description

Style:Mahogany Electric

The Mini II Bass is here to expand your horizons and your registers! Based on our popular travel-sized Mini, the Mini II Bass is slightly bigger and features an extended 580mm (22 7/8”) scale length so it tunes perfectly to Standard E. Keep it acoustic and the Mini II Bass's deeper body depth will provide a well-rounded tone; use its Cordoba MB103 pickup to plug it in and you'll be surprised by this portable bass's rich, robust tone. Built with all-mahogany woods, the Mini II Bass MHE's unique voice is mellow, soft and balanced. Strung with nylon core, phosphor-bronze strings, the Mini II Bass feels and sounds more like a full size bass than its miniature bass counterparts. With the Mini II Bass MHE, you'll never have to leave the low-end behind!

Cordoba Mini II Bass MH-E, Mahogany, Small Body, Acoustic-Electr

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA